Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer

por Schmidt, Marcus, Lenhard, Hans, Hoenig, Arnd, Zimmerman, Yvette, Krijgh, Jan, Jansen, Monique, Coelingh Bennink, Herjan J. T.
Publicado 2020

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer

por Coelingh Bennink, Herjan J. T., Schultz, Iman J., Schmidt, Marcus, Jordan, V. Craig, Briggs, Paula, Egberts, Jan F. M., Gemzell-Danielsson, Kristina, Kiesel, Ludwig, Kluivers, Kirsten, Krijgh, Jan, Simoncini, Tommaso, Stanczyk, Frank Z., Langer, Robert D.
Publicado 2023

Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review

por Coelingh Bennink, Herjan J T, Krijgh, Jan, Egberts, Jan F M, Slootweg, Maria, van Melick, Harm H E, Roos, Erik P M, Somford, Diederik M, Zimmerman, Yvette, Schultz, Iman J, Clarke, Noel W, van Moorselaar, R Jeroen A, Debruyne, Frans M J
Publicado 2022

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study

por Zimmerman, Yvette, Frydenberg, Mark, van Poppel, Hendrik, van Moorselaar, R. Jeroen A., Roos, Erik P.M., Somford, Diederik M., Roeleveld, Ton A., de Haan, Tjard D., van Melick, Harm H.E., Reisman, Yacov, Krijgh, Jan, Debruyne, Frans M.J., Coelingh Bennink, Herjan J.T.
Publicado 2022

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)

por Coelingh Bennink, Herjan J.T., van Moorselaar, Jeroen A., Crawford, E. David, Roos, Erik P.M., Somford, Diederik M., Roeleveld, Ton A., de Haan, Tjard D., van Melick, Harm H.E., Reisman, Yacov, Zimmerman, Yvette, van Osta, Gonnie, Krijgh, Jan, Shore, Neal D., Saad, Fred, Schally, Andrew V., Debruyne, Frans M.J.
Publicado 2021